Related Experiment Video
Updated: May 20, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Grey matter changes associated with medication-overuse headache: correlations with disease related disability and
Franz Riederer1, Marvin Marti, Roger Luechinger
1Department of Neurology, Headache Unit, University Hospital Zurich, Zurich, Switzerland.
Objectives:
Medication-overuse headache (MOH) is associated with psychiatric comorbidities. Neurobiological similarities to substance dependence have been suggested. This study investigated grey matter changes, focussing on pain and reward systems.
Methods:
Using voxel-based morphometry, structural MRIs were compared between 29 patients with both, MOH and migraine, according to International Headache Society criteria, and healthy controls. The Migraine Disability Assessment (MIDAS) score was used. Anxiety and depression were screened for with the Hospital Anxiety and Depression Scale (HADS) and confirmed by a psychiatrist, using the Mini International Neuropsychiatric Interview.
Results:
Nineteen patients (66%) had a present or past psychiatric disorder, mainly affective (N = 11) and anxiety disorders (N = 8). In all patients a significant increase of grey matter volume (GMV) was found in the periaqueductal grey matter of the midbrain, which correlated positively with the MIDAS and the HADS-anxiety subscale. A GMV increase was found bilaterally in the thalamus, and the ventral striatum. A significant GMV decrease was detected in frontal regions including orbitofrontal cortex, anterior cingulate cortex, the left and right insula, and the precuneus.
Conclusion:
These findings are consistent with dysfunction of antinociceptive systems in MOH, which is influenced by anxiety. Dysfunction of the reward system may be a neurobiological basis for dependence in a subgroup of MOH patients.
Insights
Medication-overuse headache (MOH) is linked to psychiatric issues. Brain imaging reveals altered grey matter in pain and reward circuits, potentially explaining dependence in some patients.
Area of Science:
- Neuroimaging
- Neurology
- Psychiatry
Background:
- Medication-overuse headache (MOH) frequently co-occurs with psychiatric conditions.
- Similarities between MOH and substance dependence suggest shared neurobiological underpinnings.
- Investigating structural brain changes in MOH is crucial for understanding its pathophysiology.
Purpose of the Study:
- To examine grey matter volume differences in patients with MOH and migraine.
- To explore the relationship between grey matter changes and psychiatric comorbidities.
- To investigate the role of pain and reward systems in MOH.
Main Methods:
- Voxel-based morphometry was used to analyze structural MRI scans.
- 29 patients with MOH and migraine were compared to healthy controls.
- Psychiatric status was assessed using standardized questionnaires and clinical interviews.
Main Results:
- Increased grey matter volume (GMV) was observed in the midbrain periaqueductal grey, thalamus, and ventral striatum.
- GMV increases correlated with headache disability and anxiety levels.
- Decreased GMV was found in frontal regions, including the orbitofrontal cortex and insula.
Conclusions:
- Findings suggest impaired antinociceptive system function in MOH, modulated by anxiety.
- Altered reward system function may underlie dependence in a subset of MOH patients.
- Structural brain changes offer insights into the neurobiology of MOH and its psychiatric links.
Related Concept Videos
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
Generalized Anxiety Disorder
Alzheimer Disease l: Introduction
